MELISSA POLIZOS: Open Payments
NPI 1215511274 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 19 payments from 7 companies in 2025. Trend: 2023 $1,733 · 2024 $350 · 2025 $479
Food & beverage: $423Education: $56
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $207 |
| GlaxoSmithKline, LLC. | 6 | $110 |
| GENZYME CORPORATION | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Paratek Pharmaceuticals, Inc. | 1 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $19 |
Products named: DUPIXENT, NUCALA, XHANCE, Rhapsido, NEFFY.
Industry payments across VA — which companies pay providers there.
